| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | $13,6550 | -2,18% | $838,42M | $1,08M | |
| $46,2390 | -3,49% | $837,92M | $100,83K | |
| $19,7400 | -0,40% | $836,70M | $141,32K | |
EVC Entravision Communication | $8,7550 | -2,83% | $835,71M | $1,34M | |
ETON Eton Pharmaceutcials, Inc. Common Stock | $27,1610 | -0,87% | $834,09M | $215,88K | |
| $25,9070 | -3,51% | $832,22M | $98,62K | |
AMPH Amphastar Pharmaceuticals, Inc. | $17,9800 | -2,55% | $831,15M | $285,05K | |
MATW Matthews International Corp | $25,3910 | -2,72% | $828,11M | $140,86K | |
TBPH Theravance Biopharma, Inc. | $15,8740 | +1,89% | $827,94M | $209,62K | |
MPB Mid Penn Bancorp, Inc. | $31,6450 | -3,77% | $827,51M | $115,54K | |
KRO Kronos Worldwide, Inc. | $7,0550 | -2,42% | $827,23M | $109,33K | |
ADAM Adamas Trust, Inc. Common Stock | $8,8150 | -2,60% | $826,72M | $424,12K | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | $21,8950 | -0,21% | $824,89M | $20,08K | |
ROOT Root, Inc. Class A Common Stock | $52,1700 | -6,37% | $823,91M | $177,35K | |
EOI Eaton Vance Enhanced Equity Income Fund | $19,8100 | -0,65% | $823,31M | $51,80K | |
